Saw Swee Hock School of Public Health, National University of Singapore and National University Hospital System, Singapore.
Infectious Disease Research and Training Office, National Centre for Infectious Diseases, Singapore.
J Infect Dis. 2019 May 24;219(12):1913-1923. doi: 10.1093/infdis/jiz046.
Few studies have evaluated the relative cross-protection conferred by infection with different groups of viruses through studies of sequential infections in humans. We investigated the presence of short-lived relative cross-protection conferred by specific prior viral infections against subsequent febrile respiratory illness (FRI).
Men enlisted in basic military training between December 2009 and December 2014 were recruited, with the first FRI as the study entry point. ResPlex II assays and real-time polymerase chain reaction assays were used to detect viral pathogens in nasal wash samples, and survival analyses were performed to determine whether infection with particular viruses conferred short-lived relative cross-protection against FRI.
Prior infection with adenovirus (hazard ratio [HR], 0.24; 95% confidence interval [CI], .14-.44) or influenza virus (HR, 0.52; 95% CI, .38-.73) conferred relative protection against subsequent FRI episode. Results were statistically significant even after adjustment for the interval between enlistment and FRI (P < .001). Adenovirus-positive participants with FRI episodes tended to be protected against subsequent infection with adenovirus, coronavirus, enterovirus/rhinovirus, and influenza virus (P = .062-.093), while men with influenza virus-positive FRI episodes tended be protected against subsequent infection with adenovirus (P = .044) and influenza virus (P = .081).
Prior adenovirus or influenza virus infection conferred cross-protection against subsequent FRI episodes relative to prior infection due to other circulating viruses.
通过对人类先后感染的研究,评估不同组别的病毒感染导致的相对交叉保护作用的研究甚少。我们调查了特定的先前病毒感染对随后的发热性呼吸道疾病(FRI)产生的短暂相对交叉保护作用的存在情况。
我们招募了 2009 年 12 月至 2014 年 12 月期间入伍的新兵,以首次发生 FRI 作为研究的切入点。使用 ResPlex II 检测试剂盒和实时聚合酶链反应检测试剂盒检测鼻洗液样本中的病毒病原体,并进行生存分析,以确定特定病毒感染是否对 FRI 产生短暂的相对交叉保护作用。
先前感染腺病毒(危险比 [HR],0.24;95%置信区间 [CI],0.14-0.44)或流感病毒(HR,0.52;95%CI,0.38-0.73)与随后发生 FRI 发作具有相关性。即使在调整入伍与 FRI 发作之间的间隔时间后,结果仍具有统计学意义(P <.001)。发生 FRI 发作的腺病毒阳性参与者倾向于对随后的腺病毒、冠状病毒、肠病毒/鼻病毒和流感病毒感染产生保护作用(P =.062-.093),而发生流感病毒阳性 FRI 发作的男性倾向于对随后的腺病毒(P =.044)和流感病毒(P =.081)感染产生保护作用。
先前的腺病毒或流感病毒感染相对于其他循环病毒的感染对随后的 FRI 发作具有交叉保护作用。